Cytokines in cancer immunotherapy.

Lee S, Margolin K. · 2011

Read Cytokines in cancer immunotherapy. by Lee S, Margolin K. (2011) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3763400.txt.

Description

Sylvia Lee and Kim Margolin wrote a review in Cancers in 2011 on cytokines in cancer immunotherapy. Cytokines are messenger proteins that let immune cells coordinate a strong but self-limited attack. As interest grew in using the immune system against cancer, so did work on exploiting these signals as drugs.

The review covers the major cytokines in cancer treatment, their biology, and their clinical uses. Two, including high-dose interleukin-2, had won approval as single agents by then. Others, such as GM-CSF, IL-7, IL-12, and IL-21, were in trials for advanced cancer, and work was under way on blocking suppressive cytokines such as IL-10. The authors also discuss new cytokines in early development, drug combinations, and novel delivery methods.

Catalog record

CREATORLee S, Margolin K.
YEAR2011
COLLECTIONPAPERS
FORMATTXT
FILE SIZE111 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC3763400

Browse the full library · About the Tower of Babel